NCT05394246View on ClinicalTrials.gov

Fluorescent-labeled IgG for Liver Tumor Detection

NAUnknownINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

May 20, 2022

Primary Completion Date

December 31, 2024

Study Completion Date

June 30, 2025

Conditions
Liver Cancer
Interventions
DRUG

FluoAB

Drug Injection: FluoAB (fluorescent-labeled IgG)

Trial Locations (1)

Unknown

RECRUITING

The Affiliated Hospital of Southwest Medical University, Luzhou

Sponsors
All Listed Sponsors
lead

Chinese Academy of Sciences

OTHER_GOV

NCT05394246 - Fluorescent-labeled IgG for Liver Tumor Detection | Biotech Hunter | Biotech Hunter